Latest News and Press Releases
Want to stay updated on the latest news?
-
Research Triangle Park, N.C., April 08, 2025 (GLOBE NEWSWIRE) -- Dr. Sepp-Lorenzino brings to AskBio over 30 years of executive, academic, and Board experienceOther Board positions include Taysha...
-
Austin, TX, USA, March 31, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Home Gardening Market Size, Trends and Insights By Gardener Type (Professional...
-
Research Triangle Park, N.C., March 07, 2025 (GLOBE NEWSWIRE) -- Data Safety Monitoring Board (DSMB) recommendation to initiate second cohort follows review of Phase 1/Phase 2 LION-CS101 trial...
-
Austin, TX, USa, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Synthetic Biology Market Size, Trends and Insights By Tool (Oligonucleotides and...
-
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib...
-
Research Triangle Park, N.C., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart...
-
Berlin, Germany, and Research Triangle Park, N.C., USA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Enrollment ongoing in the United States for REGENERATE-PD clinical trial of...
-
Research Triangle Park, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- First patient dosed in Phase 1/Phase 2 LION-CS101 trial of AB-1003 in August 2023, with enrollment continuing Asklepios...
-
Research Triangle Park, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Two oral presentations and nine poster presentations will highlight exciting progress in AskBio’s clinical and pre-clinical...
-
Berlin, Germany, and Research Triangle Park, N.C., USA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Not intended for UK Media AskBio and Belief BioMed will work together to advance potential gene...